Agree. But if the trial design doesn't pass, the fact that it's safe, etc., won't matter. At the end of the day, they want a drug that works. They won't approve it just because it's safe. It must work. We think it does, 50 scientists do as well, but it's really up to those 8-10 people to test it and determine that it works.
Market Data 
Markets 
